PreciseDx Breast test study for invasive breast cancer
Part of Cancer, Skin clinical trials.
This study tests a new diagnostic tool called PreciseDx Breast designed to help guide treatment decisions for people with invasive breast cancer. It may help your doctor understand your cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with invasive breast cancer (the kind that has spread beyond the milk ducts).
- Your cancer is ductal or a mix of ductal and lobular types.
- You have not had invasive breast cancer before.
- You have not received chemotherapy or other treatments before surgery (neoadjuvant therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special test (DCISionRT) on tissue from your breast surgery to help doctors decide if radiation therapy is right for you after lumpectomy for DCIS (a non-invasive form of breast cancer). The goal is to personalize treatment based on your individual cancer characteristics.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
This study is testing a research tool that may help doctors choose the best treatment for people with advanced triple-negative breast cancer. You will have a biopsy and blood draw to help see how the tool works.
This trial tests a new type of breast imaging (Positron Emission Mammography) to see how well it finds breast cancer. It's for people who may have breast cancer and want a more detailed scan.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.